{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T02:43:00Z","timestamp":1776652980040,"version":"3.51.2"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019205","name":"National Rice Research Institute, Indian Council of Agricultural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010809","name":"Jascha Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020033","name":"Alzheimer-forskningsfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008267","name":"Kong Christian den Tiendes Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008267","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003035","name":"Aase og Ejnar Danielsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Overretssagf\u00f8rer L. Zeuthens Mindelegat"},{"DOI":"10.13039\/501100009908","name":"Grosserer L. F. Foghts Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009908","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008262","name":"Harboefonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008262","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ellen M\u00f8rchs Fond"},{"name":"National Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We investigated profiles of clinical symptoms and kinetic \u03b1-synuclein seed amplification assay (\u03b1Syn-SAA) parameters in skin across the spectrum of Lewy body disease by comparing normosmic healthy controls (HC), individuals with idiopathic olfactory dysfunction (iOD), and dementia with Lewy bodies (DLB) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cross-sectional, case\u2013control study, we included 49 \u03b1Syn-SAA-negative HC, 18 \u03b1Syn-SAA-positive iOD, and 25 \u03b1Syn-SAA-positive DLB patients. \u03b1Syn-SAA was performed on olfactory mucosa swabs and skin biopsies. Only the skin-derived kinetic parameters were explored for comparative kinetic analysis (13 iOD and 24 DLB). Clinical assessments included the Sniffin\u2019 Sticks 16 for olfaction, Montreal Cognitive Assessment (MoCA), REM Sleep Behavior Disorder Single-Question (RBD1Q), and the Movement Disorder Society-Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS) I\u2013III.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We observed a stepwise increase in symptoms across groups from HC to iOD to DLB, measured by MoCA (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) and MDS-UPDRS I, II, III (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Participants with iOD and DLB did not differ in olfactory function (mean [SD]: 6.5 [2.4] vs. 6.0 [2.5],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.51). Accelerated \u03b1Syn seeding kinetics, particularly shorter time to 50% of maximal fluorescence, were detected in DLB vs iOD (median hours [interquartile range] 17 [15\u201320] vs 14 [13\u201316],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017), achieving a classification accuracy of 74% (95% CI 57\u201391), and correlated with number of symptoms related to DLB without and with adjusting for age and sex (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002,\n                      <jats:italic>R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.605).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings delineate the Lewy body symptom profile in iOD positioning iOD as a prodromal stage in which peripheral \u03b1Syn aggregation kinetics can be detected.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-026-13745-w","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:55:07Z","timestamp":1773665707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correlating symptoms and skin \u03b1-synuclein seeding parameters in olfactory dysfunction and Lewy body dementia"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9728-8773","authenticated-orcid":false,"given":"Oskar H.","family":"McWilliam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remarh","family":"Bsoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Au\u0161rin\u0117","family":"Are\u0161kevi\u010di\u016bt\u0117","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida S. B.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Bruun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"von Buchwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steen G.","family":"Hasselbalch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva L.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian K.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja H.","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunhild","family":"Waldemar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasper","family":"Aan\u00e6s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian S.","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"13745_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U et al (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"13745_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt274","volume":"6","author":"PC Donaghy","year":"2014","unstructured":"Donaghy PC, McKeith IG (2014) The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimers Res Ther 6:1\u201312","journal-title":"Alzheimers Res Ther"},{"key":"13745_CR3","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1093\/brain\/awz111","volume":"142","author":"SM Fereshtehnejad","year":"2019","unstructured":"Fereshtehnejad SM, Yao C, Pelletier A et al (2019) Evolution of prodromal Parkinson\u2019s disease and dementia with Lewy bodies: a prospective study. Brain 142:2051\u20132067","journal-title":"Brain"},{"key":"13745_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00415-018-9135-x","volume":"266","author":"A Haehner","year":"2019","unstructured":"Haehner A, Masala C, Walter S et al (2019) Incidence of Parkinson\u2019s disease in a large patient cohort with idiopathic smell and taste loss. J Neurol 266:339\u2013345","journal-title":"J Neurol"},{"key":"13745_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3233\/JPD-240002","volume":"14","author":"P Borghammer","year":"2024","unstructured":"Borghammer P, Okkels N, Weintraub D (2024) Parkinson\u2019s disease and dementia with Lewy bodies: one and the same. J Parkinsons Dis 14:383\u2013397","journal-title":"J Parkinsons Dis"},{"key":"13745_CR6","first-page":"1","volume":"65","author":"T Nielsen","year":"2018","unstructured":"Nielsen T, Jensen MB, Stenager E et al (2018) The use of olfactory testing when diagnosing parkinson\u2019s disease\u2014a systematic review. Dan Med J 65:1\u201310","journal-title":"Dan Med J"},{"key":"13745_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.parkreldis.2020.09.032","volume":"80","author":"YE Kim","year":"2020","unstructured":"Kim YE, Kim YJ, Hwang HS et al (2020) REM sleep behavior disorder in early Parkinson\u2019s disease predicts the rapid dopaminergic denervation. Park Relat Disord 80:120\u2013126","journal-title":"Park Relat Disord"},{"key":"13745_CR8","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1002\/alz.13105","volume":"19","author":"PC Donaghy","year":"2023","unstructured":"Donaghy PC, Carrarini C, Ferreira D et al (2023) Research diagnostic criteria for mild cognitive impairment with Lewy bodies: a systematic review and meta-analysis. Alzheimers Dement 19:3186\u20133202","journal-title":"Alzheimers Dement"},{"key":"13745_CR9","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/mds.24996","volume":"27","author":"RB Postuma","year":"2012","unstructured":"Postuma RB, Aarsland D, Barone P et al (2012) Identifying prodromal Parkinson\u2019s disease: pre-motor disorders in Parkinson\u2019s disease. Mov Disord 27:617\u2013626","journal-title":"Mov Disord"},{"key":"13745_CR10","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/s00415-017-8521-0","volume":"264","author":"E Iannilli","year":"2017","unstructured":"Iannilli E, Stephan L, Hummel T et al (2017) Olfactory impairment in Parkinson\u2019s disease is a consequence of central nervous system decline. J Neurol 264:1236\u20131246","journal-title":"J Neurol"},{"key":"13745_CR11","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/mds.28651","volume":"36","author":"A Mammana","year":"2021","unstructured":"Mammana A, Baiardi S, Quadalti C et al (2021) RT-QuIC detection of pathological \u03b1-synuclein in skin punches of patients with Lewy body disease. Mov Disord 36:2173\u20132177","journal-title":"Mov Disord"},{"key":"13745_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/mds.27907","volume":"35","author":"S Manne","year":"2020","unstructured":"Manne S, Kondru N, Jin H et al (2020) \u03b1-synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson\u2019s disease patients. Mov Disord 35:268\u2013278","journal-title":"Mov Disord"},{"key":"13745_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-025-02034-8","volume":"13","author":"R Bsoul","year":"2025","unstructured":"Bsoul R, McWilliam OH, Waldemar G et al (2025) Accurate detection of pathologic \u03b1-synuclein in CSF, skin, olfactory mucosa, and urine with a uniform seeding amplification assay. Acta Neuropathol Commun 13:113","journal-title":"Acta Neuropathol Commun"},{"key":"13745_CR14","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/brain\/awab431","volume":"145","author":"I Poggiolini","year":"2022","unstructured":"Poggiolini I, Gupta V, Lawton M et al (2022) Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies. Brain 145:584\u2013595","journal-title":"Brain"},{"key":"13745_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-023-01653-3","volume":"11","author":"S Br\u00e4uer","year":"2023","unstructured":"Br\u00e4uer S, Rossi M, Sajapin J et al (2023) Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders. Acta Neuropathol Commun 11:1\u20139","journal-title":"Acta Neuropathol Commun"},{"key":"13745_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-021-01276-6","volume":"9","author":"K Brockmann","year":"2021","unstructured":"Brockmann K, Quadalti C, Lerche S et al (2021) Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson\u2019s disease and dementia with Lewy bodies. Acta Neuropathol Commun 9:175","journal-title":"Acta Neuropathol Commun"},{"key":"13745_CR17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210279","volume":"104","author":"DG Coughlin","year":"2025","unstructured":"Coughlin DG, Shifflett B, Farris CM et al (2025) \u03b1-synuclein seed amplification assay amplification parameters and the risk of progression in prodromal Parkinson Disease. Neurology 104:e210279","journal-title":"Neurology"},{"key":"13745_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00242-2","volume":"7","author":"A Kuzkina","year":"2021","unstructured":"Kuzkina A, Bargar C, Schmitt D et al (2021) Diagnostic value of skin RT-QuIC in Parkinson\u2019s disease: a two-laboratory study. npj Parkinsons Dis 7:99","journal-title":"npj Parkinsons Dis"},{"issue":"1","key":"13745_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41531-024-00738-7","volume":"10","author":"Y Kuang","year":"2024","unstructured":"Kuang Y, Mao H, Gan T et al (2024) A skin-specific \u03b1-synuclein seeding amplification assay for diagnosing Parkinson\u2019s disease. npj Park Dis 10(1):129. https:\/\/doi.org\/10.1038\/s41531-024-00738-7","journal-title":"npj Park Dis"},{"key":"13745_CR20","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/mds.29340","volume":"38","author":"A Kuzkina","year":"2023","unstructured":"Kuzkina A, Panzer C, Seger A et al (2023) Dermal real-time quaking-induced conversion is a sensitive marker to confirm isolated rapid eye movement sleep behavior disorder as an early \u03b1 -synucleinopathy. Mov Disord 38:1077\u20131082","journal-title":"Mov Disord"},{"issue":"4","key":"13745_CR21","first-page":"1","volume":"17","author":"OH McWilliam","year":"2025","unstructured":"McWilliam OH, Bsoul R, Lund EL et al (2025) \u03b1 -synuclein seed amplification assay in Lewy body dementia versus alzheimer\u2019s disease. Alzheimer\u2019s Dement Diagn Assess Dis Monit 17(4):1\u20139","journal-title":"Alzheimer\u2019s Dement Diagn Assess Dis Monit"},{"key":"13745_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.70333","author":"OH McWilliam","year":"2025","unstructured":"McWilliam OH, Bsoul R, Waldemar G et al (2025) Prodromal Lewy body symptoms and \u03b1-synuclein seeding in idiopathic olfactory dysfunction. Mov Disord Clin Pract. https:\/\/doi.org\/10.1002\/mdc3.70333","journal-title":"Mov Disord Clin Pract"},{"key":"13745_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW et al (2017) Diagnosis and management of dementia with Lewy bodies. Neurology 89:88\u2013100","journal-title":"Neurology"},{"key":"13745_CR24","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","volume":"94","author":"IG McKeith","year":"2020","unstructured":"McKeith IG, Ferman TJ, Thomas AJ et al (2020) Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology 94:743\u2013755","journal-title":"Neurology"},{"key":"13745_CR25","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1002\/lary.27052","volume":"128","author":"AS Niklassen","year":"2018","unstructured":"Niklassen AS, Ovesen T, Fernandes H et al (2018) Danish validation of sniffin\u2019 sticks olfactory test for threshold, discrimination, and identification. Laryngoscope 128:1759\u20131766","journal-title":"Laryngoscope"},{"key":"13745_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695\u2013699","journal-title":"J Am Geriatr Soc"},{"key":"13745_CR27","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR et al (2008) Movement disorder society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129\u20132170","journal-title":"Mov Disord"},{"key":"13745_CR28","first-page":"1","volume":"11","author":"M Bongianni","year":"2022","unstructured":"Bongianni M, Catalan M, Perra D et al (2022) Olfactory swab sampling optimization for \u03b1-synuclein aggregate detection in patients with Parkinson\u2019s disease. Transl Neurodegener 11:1\u201311","journal-title":"Transl Neurodegener"},{"key":"13745_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0326568","volume":"20","author":"R Bsoul","year":"2025","unstructured":"Bsoul R, Simonsen AH, Frederiksen KS et al (2025) Seeding amplification assay with universal control fluid: standardized detection of \u03b1-synucleinopathies. PLoS ONE 20:1\u201316","journal-title":"PLoS ONE"},{"key":"13745_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0508-2","volume":"6","author":"BR Groveman","year":"2018","unstructured":"Groveman BR, Orr\u00f9 CD, Hughson AG et al (2018) Rapid and ultra-sensitive quantitation of disease-associated \u03b1-synuclein seeds in brain and cerebrospinal fluid by \u03b1Syn RT-QuIC. Acta Neuropathol Commun 6:7","journal-title":"Acta Neuropathol Commun"},{"key":"13745_CR31","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41596-022-00787-3","volume":"18","author":"L Concha-Marambio","year":"2023","unstructured":"Concha-Marambio L, Pritzkow S, Shahnawaz M et al (2023) Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid. Nat Protoc 18:1179\u20131196","journal-title":"Nat Protoc"},{"key":"13745_CR32","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1002\/mds.27189","volume":"32","author":"D Weintraub","year":"2017","unstructured":"Weintraub D, Chahine LM, Hawkins KA et al (2017) Cognition and the course of prodromal Parkinson\u2019s disease. Mov Disord 32:1640\u20131645","journal-title":"Mov Disord"},{"key":"13745_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines12102257","volume":"12","author":"K Bochniak","year":"2024","unstructured":"Bochniak K, Soszy\u0144ski M, Madetko-Alster N et al (2024) Current perspectives on olfactory loss in Atypical Parkinsonisms\u2014a review article. Biomedicines 12:1\u201313","journal-title":"Biomedicines"},{"key":"13745_CR34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/chemse\/bjw061","volume":"41","author":"P Kohli","year":"2016","unstructured":"Kohli P, Soler ZM, Nguyen SA et al (2016) The association between olfaction and depression: a systematic review. Chem Senses 41:479\u2013486","journal-title":"Chem Senses"},{"key":"13745_CR35","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/mds.24892","volume":"27","author":"A Siderowf","year":"2012","unstructured":"Siderowf A, Jennings D, Eberly S et al (2012) Impaired olfaction and other prodromal features in the Parkinson at-risk syndrome study. Mov Disord 27:406\u2013412","journal-title":"Mov Disord"},{"key":"13745_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00519-8","author":"A Kuzkina","year":"2023","unstructured":"Kuzkina A, R\u00f6\u00dfle J, Seger A et al (2023) Combining skin and olfactory \u03b1-synuclein seed amplification assays (SAA)\u2014towards biomarker-driven phenotyping in synucleinopathies. npj Park Dis. https:\/\/doi.org\/10.1038\/s41531-023-00519-8","journal-title":"npj Park Dis"},{"key":"13745_CR37","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/brain\/awab005","volume":"144","author":"A Stefani","year":"2021","unstructured":"Stefani A, Iranzo A, Holzknecht E et al (2021) Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder. Brain 144:1118\u20131126","journal-title":"Brain"},{"key":"13745_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jamaneurol.2016.4547","volume":"74","author":"M Shahnawaz","year":"2017","unstructured":"Shahnawaz M, Tokuda T, Waraga M et al (2017) Development of a biochemical diagnosis of Parkinson disease by detection of \u03b1-synuclein misfolded aggregates in cerebrospinal fluid. JAMA Neurol 74:163\u2013172","journal-title":"JAMA Neurol"},{"key":"13745_CR39","first-page":"1","volume":"10","author":"K Brockmann","year":"2024","unstructured":"Brockmann K, Lerche S, Baiardi S et al (2024) CSF \u03b1-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson\u2019s disease. npj Park Dis 10:1\u20139","journal-title":"npj Park Dis"},{"key":"13745_CR40","first-page":"1","volume":"17","author":"M Verdurand","year":"2025","unstructured":"Verdurand M, Kaczorowski F, Dautricourt S et al (2025) Toward alpha-synuclein seed amplification assay in clinical practice. Alzheimer\u2019s Dement Diagn Assess Dis Monit 17:1\u201311","journal-title":"Alzheimer\u2019s Dement Diagn Assess Dis Monit"},{"key":"13745_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1193458","author":"C Pe\u00f1a-Bautista","year":"2023","unstructured":"Pe\u00f1a-Bautista C, Kumar R, Baquero M et al (2023) Misfolded alpha-synuclein detection by RT-QuIC in dementia with Lewy bodies: a systematic review and meta-analysis. Front Mol Biosci. https:\/\/doi.org\/10.3389\/fmolb.2023.1193458","journal-title":"Front Mol Biosci"},{"key":"13745_CR42","first-page":"1","volume":"7","author":"C Quadalti","year":"2021","unstructured":"Quadalti C, Calandra-Buonaura G, Baiardi S et al (2021) Neurofilament light chain and \u03b1-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes. npj Park Dis 7:1\u20138","journal-title":"npj Park Dis"},{"key":"13745_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi M, Candelise N, Baiardi S et al (2020) Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol 140:49\u201362","journal-title":"Acta Neuropathol"},{"key":"13745_CR44","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni T, Chahine LM, Poston K et al (2024) A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research. Lancet Neurol 23:178\u2013190","journal-title":"Lancet Neurol"},{"key":"13745_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105285","author":"SY Chiu","year":"2023","unstructured":"Chiu SY, Wyman-Chick KA, Ferman TJ et al (2023) Sex differences in dementia with Lewy bodies: focused review of available evidence and future directions. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105285","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13745-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13745-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13745-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T01:48:22Z","timestamp":1776649702000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13745-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["13745"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13745-w","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest relevant to this work. Extended author information available on the last page of the article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Ethical approval was granted by the Regional Committee on Health Research Ethics for the Capital Region of Denmark (H-22053428; H-22046053), and the study was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants prior to inclusion.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"210"}}